Literature DB >> 9655712

Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.

M Levi1, T van Der POLL, H ten CATE, B Kuipers, B J Biemond, H M Jansen, J W ten CATE.   

Abstract

Activation and inhibition of coagulation and fibrinolysis was analyzed in bronchoalveolar lavage (BAL) fluids obtained from endotoxin-challenged chimpanzees. The mediatory role of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) on endotoxin-induced changes in bronchoalveolar coagulation and fibrinolysis was investigated in experiments in which the infusion of endotoxin was combined with the administration of monoclonal anti-TNF-alpha or anti-IL-6 antibodies. Endotoxin infusion elicited a marked increase in bronchoalveolar thrombin generation as measured by levels of prothrombin activation fragment F1+2 and thrombin-antithrombin complexes. Markers for intrinsic pathway activation were not detectable, suggesting that the thrombin generation was mediated by the tissue factor-dependent route. Levels of antithrombin were low before the injection of endotoxin and not detectable hereafter. The administration of anti-IL-6 antibody completely abolished the endotoxin-induced activation of bronchoalveolar coagulation, whereas treatment with anti-TNF-alpha antibody only partly inhibited this effect. Bronchoalveolar fibrinolytic activity, due to urokinase-type plasminogen activator (u-PA), was significantly depressed after endotoxin injection, mainly due to a striking increase in plasminogen activator inhibitor-2 levels in BAL fluid. The endotoxin-induced effects on bronchoalveolar fibrinolysis could be blocked by the simultaneous administration of anti- TNF-alpha antibodies. We conclude that endotoxemia results in the activation of bronchoalveolar coagulation, which is apparently mediated by the tissue factor route of coagulation activation and which may be amplified by consumption of antithrombin III. Bronchoalveolar fibrinolytic activity is significantly abolished by increased levels of mainly PAI-2 after the injection of endotoxin. The endotoxin-induced effects on bronchoalveolar coagulation appears to be mediated by IL-6, whereas TNF-alpha seems to be the pivotal mediator of the endotoxin-induced depression of bronchoalveolar fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655712     DOI: 10.1164/ajrccm.158.1.9709007

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

1.  Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice.

Authors:  Rafal Pawlinski; Jian-Guo Wang; A Phillip Owens; Julie Williams; Silvio Antoniak; Michael Tencati; Thomas Luther; Jesse W Rowley; Elizabeth N Low; Andrew S Weyrich; Nigel Mackman
Journal:  Blood       Date:  2010-04-21       Impact factor: 22.113

2.  Bronchoscopic Intrapulmonary Recombinant Factor VIIa for Diffuse Alveolar Hemorrhage-induced Acute Respiratory Failure in MPO-ANCA Vasculitis: A Case Report.

Authors:  Illaa Smesseim; Titia Schaepman-Ruys; Jan Willem Duitman; Yosta Vegting; Jorinde Raasveld; Marc Hilhorst; Alexander Vlaar; Josien van Es; Peter Bonta
Journal:  J Crit Care Med (Targu Mures)       Date:  2022-05-12

3.  Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices.

Authors:  Sean T Zuckerman; James F Brown; Weiyuan J Kao
Journal:  Biomaterials       Date:  2009-05-14       Impact factor: 12.479

4.  Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.

Authors:  Nicola Semeraro; Concetta T Ammollo; Fabrizio Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-13       Impact factor: 2.576

5.  Procoagulant and fibrinolytic activity in ventilator-associated pneumonia: impact of inadequate antimicrobial therapy.

Authors:  Ali A El-Solh; Mifue Okada; Celestino Pietrantoni; Alan Aquilina; Eileen Berbary
Journal:  Intensive Care Med       Date:  2004-07-23       Impact factor: 17.440

Review 6.  Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies.

Authors:  Jenny Juschten; Pieter R Tuinman; Nicole P Juffermans; Barry Dixon; Marcel Levi; Marcus J Schultz
Journal:  Ann Transl Med       Date:  2017-11

Review 7.  Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.

Authors:  Marcel Levi; Tom van der Poll; Marcus Schultz
Journal:  Semin Immunopathol       Date:  2011-07-30       Impact factor: 9.623

8.  Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage.

Authors:  Lars Heslet; Jorn Dalsgaard Nielsen; Marcel Levi; Henrik Sengeløv; Pär I Johansson
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

9.  Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer.

Authors:  Raúl Carrillo Esper; Isis Espinoza de Los Monteros Estrada; Teresa de la Torre León; Agustín Omar Rosales Gutiérrez; Jorge Arturo Nava López
Journal:  J Intensive Care       Date:  2014-08-27

10.  Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response.

Authors:  Laurent Robriquet; François Collet; Antoine Tournoys; Thierry Prangère; Rémi Nevière; François Fourrier; Benoît P Guery
Journal:  Respir Res       Date:  2006-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.